Advances in the treatment of chronic viral hepatitis

JAMA

Volumn 282, Issue 6, 1999, Pages 511-512

  Koff, Raymond S ^a,b,c  

^a Metro West Medical Center   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2A INTERFERON; ALPHA2B INTERFERON; ANTISENSE OLIGONUCLEOTIDE; HELICASE; HEPATITIS B(E) ANTIGEN; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; LAMIVUDINE; MACROPHAGE ACTIVATING FACTOR; NUCLEOSIDE DERIVATIVE; PROTEINASE INHIBITOR; RIBAVIRIN; RIBOZYME; RNA DIRECTED RNA POLYMERASE; THYMOSIN; VACCINE; VIRUS RNA;

BONE MARROW SUPPRESSION; COST EFFECTIVENESS ANALYSIS; DELTA AGENT HEPATITIS; DEPRESSION; FLU LIKE SYNDROME; GENOTYPE; HEMOLYTIC ANEMIA; HEPATITIS B; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER FAILURE; LIVER TRANSPLANTATION; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS HEPATITIS; VIRUS LOAD;

EID: 0033546670     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.6.511     Document Type: Short Survey

References (12)

1. Bonkovsky HL, Woolley JM, for the Consensus Interferon Study Group. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology. 1999;29:264-270.
2. Niederau C, Heintges T, Lange S, et al. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med. 1996; 334:1422-1427.
3. Niederau C, Lange S, Heintges T, et al. Prognosis of chronic hepatitis C. Hepatology. 1998;29:1687-1695.
4. McQuillan GM, Coleman PJ, Kruszon-Moran D, et al. Prevalence of hepatitis B virus infection in the United States. Am J Public Health. 1999;89:14-18.
5. Wong JB, Bennett WG, Koff RS, Pauker SG. Pre-treatment evaluation of chronic hepatitis C: risks, benefits, and costs. JAMA. 1998;280:2088-2093.
6. Hoofnagle JH, Di Bisceglie AM. Treatment of chronic viral hepatitis. N Engl J Med. 1997;336:347-353.
7. Marcellin P, Boyer N, Gervais A, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med. 1997;127:875-881.
8. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med. 1998;339:1485-1492.
9. Davis GL, Esteban-Mur R, Rustgi V, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med. 1998;339:1493-1499.
10. Heathcote EJ, Keeffe EB, Lee SS, et al. Retreatment of chronic hepatitis C with consensus interferon. Hepatology. 1998;27:1136-1143.
11. Lai CL, Chien RN, Leung NWY, et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med. 1998;339:61-68.
12. Malaguarnera M, Restuccia S, Pistone G, Ruello P, Giugno I, Trovato BA. A meta-analysis of interferon alpha treatment of hepatitis D virus infection. Pharmacotherapy. 1996;16:609-614.